✦ LIBER ✦

PDB11 CLINICAL AND COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 ONCE OR TWICE DAILY VERSUS INSULIN GLARGINE IN TYPE 2 DIABETES MELLITUS: A MODELING ANALYSIS IN THE CHINESE SETTING

✍ Scribed by Palmer, JL; Beaudet, A; White, J; Plun-Favreau, J; Smith-Palmer, J

Book ID: 122177203
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 66 KB
Volume: 13
Category: Article
ISSN: 1098-3015
DOI: 10.1016/S1098-3015(11)73186-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB23 COST-EFFECTIVENESS OF BIPHASIC INS

PDB23 COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 VERSUS HUMAN PREMIX INSULIN FOR TYPE 2 DIABETES PATIENTS IN A POLISH SETTING

✍ M Aristides; R Kotchie; S Nielsen; C Townsend; WJ Valentine; H Scheijbeler 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

A Comparison of Twice-Daily Biphasic Ins

A Comparison of Twice-Daily Biphasic Insulin Aspart 70/30 and Once-Daily Insulin Glargine in Persons with Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Therapy: A Randomized, Open-Label Study

✍ Ligthelm, Robert; Gylvin, Titus; DeLuzio, Tony; Raskin, Philip 📂 Article 📅 2011 🏛 American Association of Clinical Endocrinologists 🌐 English ⚖ 781 KB

PDB51 COST-EFFECTIVENESS OF EXENATIDE VE

PDB51 COST-EFFECTIVENESS OF EXENATIDE VERSUS INSULIN GLARGINE AND VERSUS BIPHASIC INSULIN ASPART FOR THE TREATMENT OF TYPE 2 DIABETES IN PORTUGAL: A LONG-TERM HEALTH ECONOMIC ANALYSIS

✍ JL Palmer; CG Pinto; R Duarte; L Miguel; Z Gregor 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Insulin therapy in type 2 diabetes patie

Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US

✍ J. A. Ray; W. J. Valentine; S. Roze; L. Nicklasson; D. Cobden; P. Raskin; A. Gar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

PDB24 COST EFFECTIVENESS ANALYSIS OF SWI

PDB24 COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO BIPHASIC INSULIN ASPART 30 FROM BIPHASIC HUMAN INSULIN 30 IN THE CZECH SETTING

✍ E Suchankova; T Doležal; Z Pisarikova; K Rychna; D Bartaskova 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

PDB30 EVALUATING THE COST-EFFECTIVENESS

PDB30 EVALUATING THE COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 VERSUS HUMAN PREMIX INSULIN FOR THE TREATMENT OFTYPE 2 DIABETES IN A SPANISH SETTING

✍ D Tucker; WJ Valentine; S Nielsen; C Townsend; R Kotchie; H Scheijbeler 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB